3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

3
U.S. (TOLL FREE)
+1 (315) 215-3225
Micro-RNA Sequencing and Assay - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-13U7595
Home | Market Reports | Science| Biological Sciences
Global Micro RNA Sequencing and Assay Market Insights and Forecast to 2028
BUY CHAPTERS

Micro-RNA Sequencing and Assay - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13U7595
Report
October 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Micro-RNA Sequencing and Assay - Market Size

The global market for Micro-RNA Sequencing and Assay was estimated to be worth US$ 231 million in 2023 and is forecast to a readjusted size of US$ 429.3 million by 2030 with a CAGR of 9.8% during the forecast period 2024-2030

Micro-RNA Sequencing and Assay - Market

Micro-RNA Sequencing and Assay - Market

MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.Like other miRNA profiling technologies, miRNA-Seq has both advantages (sequence-independence, coverage) and disadvantages (high cost, infrastructure requirements, run length, and potential artifacts).
North American market for Micro-RNA Sequencing and Assay was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Micro-RNA Sequencing and Assay was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Micro-RNA Sequencing and Assay was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Micro-RNA Sequencing and Assay include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Micro-RNA Sequencing and Assay, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Micro-RNA Sequencing and Assay by region & country, by Type, and by Application.
The Micro-RNA Sequencing and Assay market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Micro-RNA Sequencing and Assay.
Market Segmentation

Scope of Micro-RNA Sequencing and Assay - Market Report

Report Metric Details
Report Name Micro-RNA Sequencing and Assay - Market
Forecasted market size in 2030 US$ 429.3 million
CAGR 9.8%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Research Institute
  • Academia
  • CRO
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio, NEB
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Micro-RNA Sequencing and Assay manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Micro-RNA Sequencing and Assay in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Micro-RNA Sequencing and Assay in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Micro-RNA Sequencing and Assay - Market size in 2030?

Ans: The Micro-RNA Sequencing and Assay - Market size in 2030 will be US$ 429.3 million.

Who are the main players in the Micro-RNA Sequencing and Assay - Market report?

Ans: The main players in the Micro-RNA Sequencing and Assay - Market are Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio, NEB

What are the Application segmentation covered in the Micro-RNA Sequencing and Assay - Market report?

Ans: The Applications covered in the Micro-RNA Sequencing and Assay - Market report are Research Institute, Academia, CRO

What are the Type segmentation covered in the Micro-RNA Sequencing and Assay - Market report?

Ans: The Types covered in the Micro-RNA Sequencing and Assay - Market report are Sequencing by Synthesis, Sequencing by Nanopore, Ion Semiconductor Sequencing

Recommended Reports

RNA Sequencing Markets

miRNA-related Markets

Sequencing Technology

1 Market Overview
1.1 Micro-RNA Sequencing and Assay Product Introduction
1.2 Global Micro-RNA Sequencing and Assay Market Size Forecast
1.3 Micro-RNA Sequencing and Assay Market Trends & Drivers
1.3.1 Micro-RNA Sequencing and Assay Industry Trends
1.3.2 Micro-RNA Sequencing and Assay Market Drivers & Opportunity
1.3.3 Micro-RNA Sequencing and Assay Market Challenges
1.3.4 Micro-RNA Sequencing and Assay Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Micro-RNA Sequencing and Assay Players Revenue Ranking (2023)
2.2 Global Micro-RNA Sequencing and Assay Revenue by Company (2019-2024)
2.3 Key Companies Micro-RNA Sequencing and Assay Manufacturing Base Distribution and Headquarters
2.4 Key Companies Micro-RNA Sequencing and Assay Product Offered
2.5 Key Companies Time to Begin Mass Production of Micro-RNA Sequencing and Assay
2.6 Micro-RNA Sequencing and Assay Market Competitive Analysis
2.6.1 Micro-RNA Sequencing and Assay Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Micro-RNA Sequencing and Assay Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Micro-RNA Sequencing and Assay as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Sequencing by Synthesis
3.1.2 Sequencing by Nanopore
3.1.3 Ion Semiconductor Sequencing
3.2 Global Micro-RNA Sequencing and Assay Sales Value by Type
3.2.1 Global Micro-RNA Sequencing and Assay Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Micro-RNA Sequencing and Assay Sales Value, by Type (2019-2030)
3.2.3 Global Micro-RNA Sequencing and Assay Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Institute
4.1.2 Academia
4.1.3 CRO
4.2 Global Micro-RNA Sequencing and Assay Sales Value by Application
4.2.1 Global Micro-RNA Sequencing and Assay Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Micro-RNA Sequencing and Assay Sales Value, by Application (2019-2030)
4.2.3 Global Micro-RNA Sequencing and Assay Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Micro-RNA Sequencing and Assay Sales Value by Region
5.1.1 Global Micro-RNA Sequencing and Assay Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Micro-RNA Sequencing and Assay Sales Value by Region (2019-2024)
5.1.3 Global Micro-RNA Sequencing and Assay Sales Value by Region (2025-2030)
5.1.4 Global Micro-RNA Sequencing and Assay Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.2.2 North America Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.3.2 Europe Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.4.2 Asia Pacific Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.5.2 South America Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Micro-RNA Sequencing and Assay Sales Value, 2019-2030
5.6.2 Middle East & Africa Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value
6.3 United States
6.3.1 United States Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.3.2 United States Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.4.2 Europe Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.5.2 China Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.5.3 China Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.6.2 Japan Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.7.2 South Korea Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.8.2 Southeast Asia Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Micro-RNA Sequencing and Assay Sales Value, 2019-2030
6.9.2 India Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
6.9.3 India Micro-RNA Sequencing and Assay Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Profile
7.1.2 Illumina Main Business
7.1.3 Illumina Micro-RNA Sequencing and Assay Products, Services and Solutions
7.1.4 Illumina Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.1.5 Illumina Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Micro-RNA Sequencing and Assay Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 QIAGEN
7.3.1 QIAGEN Profile
7.3.2 QIAGEN Main Business
7.3.3 QIAGEN Micro-RNA Sequencing and Assay Products, Services and Solutions
7.3.4 QIAGEN Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.3.5 Takara Bio Recent Developments
7.4 Takara Bio
7.4.1 Takara Bio Profile
7.4.2 Takara Bio Main Business
7.4.3 Takara Bio Micro-RNA Sequencing and Assay Products, Services and Solutions
7.4.4 Takara Bio Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.4.5 Takara Bio Recent Developments
7.5 NEB
7.5.1 NEB Profile
7.5.2 NEB Main Business
7.5.3 NEB Micro-RNA Sequencing and Assay Products, Services and Solutions
7.5.4 NEB Micro-RNA Sequencing and Assay Revenue (US$ Million) & (2019-2024)
7.5.5 NEB Recent Developments
8 Industry Chain Analysis
8.1 Micro-RNA Sequencing and Assay Industrial Chain
8.2 Micro-RNA Sequencing and Assay Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Micro-RNA Sequencing and Assay Sales Model
8.5.2 Sales Channel
8.5.3 Micro-RNA Sequencing and Assay Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Micro-RNA Sequencing and Assay Market Trends
    Table 2. Micro-RNA Sequencing and Assay Market Drivers & Opportunity
    Table 3. Micro-RNA Sequencing and Assay Market Challenges
    Table 4. Micro-RNA Sequencing and Assay Market Restraints
    Table 5. Global Micro-RNA Sequencing and Assay Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Micro-RNA Sequencing and Assay Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Micro-RNA Sequencing and Assay Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Micro-RNA Sequencing and Assay Product Type
    Table 9. Key Companies Time to Begin Mass Production of Micro-RNA Sequencing and Assay
    Table 10. Global Micro-RNA Sequencing and Assay Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Micro-RNA Sequencing and Assay as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Micro-RNA Sequencing and Assay Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Micro-RNA Sequencing and Assay Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Micro-RNA Sequencing and Assay Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Micro-RNA Sequencing and Assay Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Micro-RNA Sequencing and Assay Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Micro-RNA Sequencing and Assay Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Micro-RNA Sequencing and Assay Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Micro-RNA Sequencing and Assay Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Micro-RNA Sequencing and Assay Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Micro-RNA Sequencing and Assay Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Micro-RNA Sequencing and Assay Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Micro-RNA Sequencing and Assay Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Micro-RNA Sequencing and Assay Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Micro-RNA Sequencing and Assay Sales Value by Region (2019-2024) & (%)
    Table 27. Global Micro-RNA Sequencing and Assay Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value, (2025-2030) & (US$ Million)
    Table 31. Illumina Basic Information List
    Table 32. Illumina Description and Business Overview
    Table 33. Illumina Micro-RNA Sequencing and Assay Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Micro-RNA Sequencing and Assay Business of Illumina (2019-2024)
    Table 35. Illumina Recent Developments
    Table 36. Thermo Fisher Scientific Basic Information List
    Table 37. Thermo Fisher Scientific Description and Business Overview
    Table 38. Thermo Fisher Scientific Micro-RNA Sequencing and Assay Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Micro-RNA Sequencing and Assay Business of Thermo Fisher Scientific (2019-2024)
    Table 40. Thermo Fisher Scientific Recent Developments
    Table 41. QIAGEN Basic Information List
    Table 42. QIAGEN Description and Business Overview
    Table 43. QIAGEN Micro-RNA Sequencing and Assay Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Micro-RNA Sequencing and Assay Business of QIAGEN (2019-2024)
    Table 45. QIAGEN Recent Developments
    Table 46. Takara Bio Basic Information List
    Table 47. Takara Bio Description and Business Overview
    Table 48. Takara Bio Micro-RNA Sequencing and Assay Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Micro-RNA Sequencing and Assay Business of Takara Bio (2019-2024)
    Table 50. Takara Bio Recent Developments
    Table 51. NEB Basic Information List
    Table 52. NEB Description and Business Overview
    Table 53. NEB Micro-RNA Sequencing and Assay Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Micro-RNA Sequencing and Assay Business of NEB (2019-2024)
    Table 55. NEB Recent Developments
    Table 56. Key Raw Materials Lists
    Table 57. Raw Materials Key Suppliers Lists
    Table 58. Micro-RNA Sequencing and Assay Downstream Customers
    Table 59. Micro-RNA Sequencing and Assay Distributors List
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
    Table 63. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Micro-RNA Sequencing and Assay Product Picture
    Figure 2. Global Micro-RNA Sequencing and Assay Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Micro-RNA Sequencing and Assay Sales Value (2019-2030) & (US$ Million)
    Figure 4. Micro-RNA Sequencing and Assay Report Years Considered
    Figure 5. Global Micro-RNA Sequencing and Assay Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Micro-RNA Sequencing and Assay Revenue in 2023
    Figure 7. Micro-RNA Sequencing and Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Sequencing by Synthesis Picture
    Figure 9. Sequencing by Nanopore Picture
    Figure 10. Ion Semiconductor Sequencing Picture
    Figure 11. Global Micro-RNA Sequencing and Assay Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Micro-RNA Sequencing and Assay Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Research Institute
    Figure 14. Product Picture of Academia
    Figure 15. Product Picture of CRO
    Figure 16. Global Micro-RNA Sequencing and Assay Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Micro-RNA Sequencing and Assay Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Micro-RNA Sequencing and Assay Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Micro-RNA Sequencing and Assay Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Micro-RNA Sequencing and Assay Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Micro-RNA Sequencing and Assay Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Micro-RNA Sequencing and Assay Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Micro-RNA Sequencing and Assay Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Micro-RNA Sequencing and Assay Sales Value (%), (2019-2030)
    Figure 29. United States Micro-RNA Sequencing and Assay Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Micro-RNA Sequencing and Assay Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Micro-RNA Sequencing and Assay Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Micro-RNA Sequencing and Assay Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Micro-RNA Sequencing and Assay Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Micro-RNA Sequencing and Assay Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Micro-RNA Sequencing and Assay Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Micro-RNA Sequencing and Assay Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Micro-RNA Sequencing and Assay Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Micro-RNA Sequencing and Assay Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Micro-RNA Sequencing and Assay Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Micro-RNA Sequencing and Assay Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Micro-RNA Sequencing and Assay Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Micro-RNA Sequencing and Assay Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Micro-RNA Sequencing and Assay Sales Value by Application (%), 2023 VS 2030
    Figure 50. Micro-RNA Sequencing and Assay Industrial Chain
    Figure 51. Micro-RNA Sequencing and Assay Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart